How do you pay?

How to pay the least

Ask for the cash price

Rezurock

We didn’t find one.

  1. Ask your pharmacy for Rezurock’s cash price, and one or two other pharmacies too.
  2. Rezurock’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameRezurock
Authorized genericbelumosudil
Regular genericbelumosudil
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Rezurock?
The original
–
–

Brand nameThe maker’s card

MyROCK ASSIST Commercial Co-pay Savings Program

Savings card from Kadmon Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on sanofimyrockassist.iassist.com 

Or call 1-844-523-6661. See the offer on rezurock.com

In the maker’s words

“Eligible commercially or privately insured people can receive REZUROCK for AS LOW AS $0 PER MONTH through the MyROCK ASSIST Commercial Co-pay Savings Program.a…”

From the maker’s offer on rezurock.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Rezurock itself, from the same company, sold without the brand name, and usually for less. For now Rezurock is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

REZUROCK is a kinase inhibitor indicated for the treatment of adult and pediatric patients 12 years and older with chronic graft-versus-host disease (chronic GVHD) after failure of at least two prior lines of systemic therapy.

Source: the FDA label for Rezurock (Kadmon Pharmaceuticals, LLC), April 7, 2026. Full label on DailyMed 

Good to know